Limited Role for Fibroblast Growth Factor 23 in Assessing Prognosis in Heart Failure Patients: Data from the TIME-CHF Trial

Robert Stöhr, Hans‐Peter Brunner‐La Rocca, Gunnar H. Heine et al.|European Journal of Heart Failure|2020

Cited by 25